Every once in a while investors will come across a ‘wow’ company. This is a company that just wows you with their performance and their stock price.
For me the ‘wow’ company of the last year is Zentek Ltd. (NASDAQ: ZTEK | TSXV: ZEN). Just take a look at the stock chart below, showing the stock rising a staggering 9.7x over the past approximately year and a half. The good news for investors is that the recent pullback allows for a better entry price than when the stock peaked at C$6.50.
Zentek Ltd (TSXV: ZEN) 5 year stock price chart
Today I give a brief summary of Zentek for new investors and an update on their progress in 2022.
Thank you for joining InvestorIntel daily email updates
Zentek describe themselves as “an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection and treatment.” I prefer to think of them as a nanotechnology and graphene company (they were formerly known as ZEN Graphene Solutions) that has expanded into multiple areas of commercialization; particularly into the healthcare sector with a product for prevention, detection and treatment of numerous pathogens.
Areas/products of commercialization for Zentek include:
Zentek’s latest news and progress in 2022
Zentek announced on February 18, 2022 the development of graphene-wrapped silicon anodes. Zentek CEO Greg Fenton stated: “Not only were the researchers able to demonstrate good performance with laboratory-scale half-cells, the performance was also validated with commercial lithium iron phosphate cathodes suggesting they could be a drop-in solution for enhancing already available battery technologies. We look forward to continuing our support of their research and development to potentially bring this technology to market. The company has begun discussions with a potential industry partner.”
As reported on February 28, 2022, Zentek’s Guelph production facility is now fully licensed and permitted for ZenGUARD™ production and substantially all equipment has been received to ramp-up industrial scale capacity. First orders have been received and the ZenGUARD™ international patent is due shortly. As reported on January 13, Zentek has entered into a binding letter of intent with GMAF Circular Medico ApS to produce and sell ZENGuard™-enhanced GMAF trademarked recyclable surgical masks.
With regards to the Pathogen Detection Technology, Zentek continues to work to bring the product to market as soon as practicable, which will require having a working prototype prepared, having conducted baseline studies, and having made applications to regulatory bodies.
With regards to Zentek’s icephobic coatings, they are currently undergoing full flight trials on a specially equipped research aircraft under real world ice-forming weather conditions.
Zentek’s new manufacturing facility in Guelph, Ontario, Canada is set for commissioning shortly
Zentek really is a ‘wow’ company with enormous potential to tap into several multi-billion dollar industries. Focusing on pathogens (viruses, bacteria, fungi) prevention, detection, and treatment is simply staggering. Then there are multiple other applications for Zentek’s products, the most recent being graphene-wrapped silicon anodes that can potentially be used to create better EV batteries and the icephobic coatings opportunity.
In terms of commercialization, Zentek is already advancing with ZenGUARD™ in terms of a production facility and orders, with the ZenGUARD™ patent due very soon and production from Zentek’s new Guelph facility set to begin very soon.
Finally, Zentek is now getting the exposure it deserves with a NASDAQ listing that began on March 22, 2022, under the ticker “ZTEK”. Not surprisingly the stock rose 25.93% on March 23.
Zentek has C$32 million in cash, no debt, and looks like being a ‘wow’ company again in 2022. Stay tuned.
Disclosure: The author is long Zentek (TSXV: ZEN).
Matthew Bohlsen is a Senior Editor for InvestorIntel.com. With a Graduate Diploma in Applied Finance and Investment, and a Graduate Diploma in Financial Planning. He ... <Read more about Matthew Bohlsen>
Copyright © 2022 InvestorIntel Corp. All rights reserved. More & Disclaimer »
What an embarrassing pump article, parroting management talking points without a shred of critical thought.
Above comment is from someone shorting the stock.
Thanks for the article. Some very interesting IP opportunities.
You should be aware that there is no deal with Evercloak. Read the press release from December 23. This is basic very diligence. You are posting misinformation. Here I will paste the article text for you:
“On July 9, 2020, the Issuer announced that Evercloak Inc. (“Evercloak”) and the Company had been awarded $125,000 each as part of a Next Generation Manufacturing Canada (“NGen”) Project, for an aggregate amount of $250,000. The project entitled “Advancing Large-Scale Graphene and Thin-Film Membrane Manufacturing” was to support the production of graphene oxide by the Company to supply to Evercloak for scale up and optimizing activities. Through this grant, and in collaboration with Evercloak, the Company was to optimize and scale-up the electrochemical exfoliation process that was developed by Prof. Aicheng Chen and his team at the University of Guelph to produce graphene oxide. On September 30, 2020, the Naval Material Technology Management section of the Royal Canadian Navy (“RCN”) partnered with the Company and Evercloak as a testing organization and agreed to provide in-kind donations of test services. The testing was completed and compared the efficiency of an HVAC unit produced with the Evercloak dehumidification membrane technology to the incumbent HVAC system that is currently in use on certain of the RCN’s frigates. Any additional testing with the RCN is currently on hold and no next steps are being considered, although Evercloak may test the suitability of the Company’s GO products (chemical and electrochemical) in its dehumidification membrane technology.”
Ok thanks Peter. I will make a correction. Regards Matt
Your email address will not be published. Required fields are marked *
Notify me of replies to this post
Notify me of new posts via email
This site uses Akismet to reduce spam. Learn how your comment data is processed.
April 21, 2022 (Source) – Kodiak Copper Corp. (TSXV: KDK) (OTCQB: KDKCF) (FSE: 5DD1) (the “Company” or “Kodiak”) is pleased to […]
April 20, 2022 (Source) – GOLD’N FUTURES MINERAL CORP. (CSE: FUTR) (FSE: G6M), (OTC: GFTRF) (the “Company” or “Gold’n Futures”) […]
NEO Battery Materials Ltd. (TSXV: NBM | OTCQB: NBMFF) (“NEO”) is advancing at full speed with their recent announcement that […]
April 20, 2022 (Source) – East Side Games Group (TSX: EAGR) (OTC: EAGRF) (“ESGG” or the “Company“), Canada’s leading free-to-play mobile game group, and Netflix […]
In this InvestorIntel interview with host Chris Thompson, Silver Bullet Mines Corp.’s (TSXV: SBMI) VP Capital Markets and Director Peter […]
Highlights Ucore is developing the Alaska Strategic Metals Complex (SMC) for the processing of rare earth elements in Southeast Alaska […]
April 19, 2022 (Source) – Ucore Rare Metals Inc. (TSXV: UCU) (OTCQX: UURAF) (FSE: U9UA) (“Ucore” or the “Company”) announces a restructuring of its wholly owned subsidiary, […]